|
Fiscal Period: December
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Capitalization1 |
66 726 | 45 639 | 44 391 | 44 742 | 56 576 | 57 036 | - | - |
Enterprise Value (EV)1 |
126 035 | 80 337 | 54 071 | 37 687 | 18 842 | 181 | 181 | 181 |
P/E ratio |
59,8x | 9,66x | 11,1x | 7,84x | 8,57x | 7,65x | 7,65x | 6,68x |
Yield |
3,62% | 5,72% | 5,79% | 2,64% | 2,83% | 2,96% | 3,12% | 3,45% |
Capitalization / Revenue |
2,29x | 1,51x | 1,58x | 1,52x | 1,72x | 1,63x | 1,62x | 1,56x |
EV / Revenue |
4,32x | 2,66x | 1,93x | 1,28x | 0,57x | 0,01x | 0,01x | 0,00x |
EV / EBITDA |
- | 10 369 675x | - | - | - | - | - | - |
Price to Book |
1,30x | 0,85x | 0,84x | 0,84x | 0,99x | 0,97x | 0,87x | 0,78x |
Nbr of stocks (in thousands) |
3 719 392 | 3 730 165 | 3 631 180 | 3 587 944 | 3 445 569 | 3 349 138 | - | - |
Reference price (CHF) |
17,9 | 12,2 | 12,2 | 12,5 | 16,4 | 17,2 | 17,2 | 17,2 |
Announcement Date |
01/22/2018 | 01/22/2019 | 01/21/2020 | 01/26/2021 | 02/01/2022 | - | - | - |
1 CHF in Million |
|
|
Income Statement Evolution (Annual data) |
|
Fiscal Period: December
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Net sales1 |
29 195 | 30 249 | 28 075 | 29 407 | 32 928 | 35 047 | 35 227 | 36 610 |
EBITDA |
- | 7 747 | - | - | - | - | - | - |
Operating profit (EBIT)1 |
5 537 | 6 474 | 5 482 | 7 929 | 8 685 | 10 060 | 9 761 | 10 367 |
Operating Margin |
19,0% | 21,4% | 19,5% | 27,0% | 26,4% | 28,7% | 27,7% | 28,3% |
Pre-Tax Profit (EBT)1 |
5 409 | 6 356 | 5 405 | 7 312 | 8 823 | 10 291 | 9 878 | 10 575 |
Net income1 |
1 165 | 4 884 | 4 171 | 5 892 | 6 937 | 7 689 | 7 163 | 7 616 |
Net margin |
3,99% | 16,1% | 14,9% | 20,0% | 21,1% | 21,9% | 20,3% | 20,8% |
EPS2 |
0,30 | 1,27 | 1,10 | 1,59 | 1,92 | 2,25 | 2,25 | 2,58 |
Dividend per Share2 |
0,65 | 0,70 | 0,71 | 0,33 | 0,47 | 0,51 | 0,54 | 0,59 |
Announcement Date |
01/22/2018 | 01/22/2019 | 01/21/2020 | 01/26/2021 | 02/01/2022 | - | - | - |
1 CHF in Million 2 CHF |
|
|
Income Statement Evolution (Quarterly data) |
|
Fiscal Period: December
|
2019 Q4 |
2020 Q1 |
2020 Q2 |
2020 Q3 |
2020 Q4 |
2021 Q1 |
2021 Q2 |
2021 Q3 |
2021 Q4 |
2022 Q1 |
2022 Q2 |
2022 Q3 |
2022 Q4 |
Net sales1 |
6 842 | 7 999 | 7 211 | 8 209 | 7 273 | 7 936 | 8 170 | 8 378 | 8 098 | 8 992 | 8 540 | 8 785 | 8 871 |
EBITDA |
- | 2 679 | - | 2 929 | 2 440 | - | - | - | - | - | - | - | - |
Operating profit (EBIT) |
907 | 2 219 | 1 735 | 2 426 | 1 887 | 2 076 | 2 308 | 2 620 | 1 582 | 2 634 | - | - | - |
Operating Margin |
13,3% | 27,7% | 24,1% | 29,6% | 25,9% | 26,2% | 28,2% | 31,3% | 19,5% | 29,3% | - | - | - |
Pre-Tax Profit (EBT) |
899 | 1 959 | 1 486 | 2 345 | 1 828 | 2 102 | 2 381 | 2 633 | 1 609 | 2 615 | - | - | - |
Net income |
700 | 1 556 | 1 157 | 1 904 | 1 518 | 1 668 | 1 842 | 2 095 | 1 254 | 2 047 | - | - | - |
Net margin |
10,2% | 19,4% | 16,1% | 23,2% | 20,9% | 21,0% | 22,5% | 25,0% | 15,5% | 22,8% | - | - | - |
EPS2 |
0,18 | 0,42 | 0,31 | 0,51 | 0,41 | 0,45 | 0,51 | 0,58 | 0,35 | 0,58 | 0,65 | 0,47 | 0,35 |
Dividend per Share |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date |
01/21/2020 | 04/28/2020 | 07/21/2020 | 10/20/2020 | 01/26/2021 | 04/27/2021 | 07/20/2021 | 10/26/2021 | 02/01/2022 | 04/26/2022 | - | - | - |
1 CHF in Million 2 CHF |
|
|
|
Fiscal Period: December
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Net Debt1 |
59 309 | 34 699 | 9 680 | - | - | - | - | - |
Net Cash position1 |
- | - | - | 7 054 | 37 735 | 56 855 | 56 855 | 56 855 |
Leverage (Debt / EBITDA) |
- | 4,48x | - | - | - | - | - | - |
Free Cash Flow |
- | - | - | - | - | - | - | - |
ROE (Net Profit / Equities) |
2,20% | 9,30% | 7,90% | 11,5% | 12,6% | 13,2% | 13,0% | 13,8% |
Shareholders' equity1 |
52 955 | 52 514 | 52 801 | 51 236 | 55 059 | 58 405 | 55 037 | 55 325 |
ROA (Net Profit / Asset) |
0,59% | 0,52% | 0,45% | 0,63% | 0,67% | 0,66% | 0,64% | 0,66% |
Assets1 |
197 147 | 946 295 | 926 957 | 932 456 | 1 043 217 | 1 168 258 | 1 117 098 | 1 160 436 |
Book Value Per Share2 |
13,8 | 14,4 | 14,6 | 14,9 | 16,6 | 17,7 | 19,8 | 22,2 |
Cash Flow per Share |
-13,3 | - | - | - | 8,03 | - | - | - |
Capex |
- | - | - | - | - | - | - | - |
Capex / Sales |
- | - | - | - | - | - | - | - |
Announcement Date |
01/22/2018 | 01/22/2019 | 01/21/2020 | 01/26/2021 | 02/01/2022 | - | - | - |
1 CHF in Million 2 CHF |
|
| |
|
|
EQT pushes back Galderma IPO plans amid market turmoil - sources |
Capitalization (CHF) |
57 035 826 390 |
Capitalization (USD) |
56 813 684 882 |
Net sales (CHF) |
32 927 746 080 |
Net sales (USD) |
32 799 500 035 |
Number of employees |
71 697 |
Sales / Employee (CHF) |
459 263 |
Sales / Employee (USD) |
457 474 |
Free-Float |
89,6% |
Free-Float capitalization (CHF) |
51 077 541 914 |
Free-Float capitalization (USD) |
50 878 606 563 |
Avg. Exchange 20 sessions (CHF) |
155 674 470 |
Avg. Exchange 20 sessions (USD) |
155 068 153 |
Average Daily Capital Traded |
0,27% |
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
|